IVD
isovaleryl-CoA dehydrogenase
IVD; isovaleryl-CoA dehydrogenase; isovaleryl CoA dehydrogenase , isovaleryl Coenzyme A dehydrogenase; isovaleryl-CoA dehydrogenase, mitochondrial; ACAD2; mitochondrial; FLJ12715; FLJ34849; Isovaleryl CoA dehydrogenase; Isovaleryl CoA dehydrogenase, mitochondrial; Isovaleryl Coenzyme A dehydrogenase; IVD_HUMAN;
Serpinb10
serpin peptidase inhibitor, clade B (ovalbumin), member 10
SERPINB10; serpin peptidase inhibitor, clade B (ovalbumin), member 10; PI10, serine (or cysteine) proteinase inhibitor, clade B (ovalbumin), member 10; serpin B10; bomapin; protease inhibitor 10 (ovalbumin type; bomapin); PI10; Protease inhibitor 10; Protease inhibitor 10 (ovalbumin type bomapin); Serpin peptidase inhibitor clade B (ovalbumin) member 10; peptidase inhibitor 10; protease inhibitor 10 (ovalbumin type, bomapin); serine (or cysteine) proteinase inhibitor, clade B (ovalbumin), member 10; PI-10;
SerpinB12
serpin peptidase inhibitor, clade B (ovalbumin), member 12
SERPINB12; serpin peptidase inhibitor, clade B (ovalbumin), member 12; serine (or cysteine) proteinase inhibitor, clade B (ovalbumin), member 12; serpin B12; YUKOPIN;
SERPINB2
Serpin Peptidase Inhibitor, Clade B (Ovalbumin), Member 2
SERPINB2; serpin peptidase inhibitor, clade B (ovalbumin), member 2; PAI; PAI2; PAI-2; PLANH2; HsT1201; plasminogen activator inhibitor 2; serpin B2; monocyte Arg-serpin; urokinase inhibitor; placental plasminogen activator inhibitor; plasminogen activator inhibitor, type II (arginine-serpin); serine (or cysteine) proteinase inhibitor, clade B (ovalbumin), member 2; OTTHUMP00000066997;
SERPINB4
serpin peptidase inhibitor, clade B (ovalbumin), member 4
SERPINB4; serpin peptidase inhibitor, clade B (ovalbumin), member 4; SCCA2, serine (or cysteine) proteinase inhibitor, clade B (ovalbumin), member 4; serpin B4; LEUPIN; PI11; SCCA 2; SCCA1; squamous cell carcinoma antigen 2; SCCA2; Peptidase inhibitor 11; PI 11; PI-11; Protease inhibitor (leucine serpin); SCCA-2; SCCA2/SCCA1 fusion protein; Serine (or cysteine) proteinase inhibitor, clade B (ovalbumin), member 4; SERPINB 4; SPB4_HUMAN; Squamous cell carcinoma antigen 1; OTTHUMP00000066807; OTTHUMP00000066808; OTTHUMP00000066810; protease inhibitor (leucine-serpin); serine (or cysteine) protein;
SERPINB5
serpin peptidase inhibitor, clade B (ovalbumin), member 5
SERPINB5; serpin peptidase inhibitor, clade B (ovalbumin), member 5; PI5; maspin; serpin B5; PI-5; peptidase inhibitor 5; protease inhibitor 5 (maspin); serine (or cysteine) proteinase inhibitor, clade B (ovalbumin), member 5;
SERPINB3
serpin peptidase inhibitor, clade B (ovalbumin), member 3
SERPINB3; serpin peptidase inhibitor, clade B (ovalbumin), member 3; SCC, SCCA1, serine (or cysteine) proteinase inhibitor, clade B (ovalbumin), member 3; serpin B3; HsT1196; T4 A; Protein T4 A; Protein T4-A; SCCA-1; SCCA1; SCCAPD; SPB3_HUMAN; Squamous cell carcinoma antigen 1; T4A; OTTHUMP00000066804; OTTHUMP00000066805; serine (or cysteine) proteinase inhibitor, clade B (ovalbumin), member 3; SCC; T4-A; SCCA-PD;
SerpinB1
serpin peptidase inhibitor, clade B (ovalbumin), member 1
SERPINB1; serpin peptidase inhibitor, clade B (ovalbumin), member 1; ELANH2, serine (or cysteine) proteinase inhibitor, clade B (ovalbumin), member 1; leukocyte elastase inhibitor; anti elastase; EI; PI2; ELANH2; ILEU_HUMAN; LEI; M/NEI; MNEI; Monocyte/neutrophil elastase inhibitor; Peptidase inhibitor 2; Pi-2; Serine (or cysteine) proteinase inhibitor clade B (ovalbumin) member 1; Serpin B1; Serpin peptidase inhibitor clade B (ovalbumin) member 1; anti-elastase; protease inhibitor 2 (anti-elastase), monocyte/neutrophil derived; serine (or cysteine) proteinase inhibitor, clade B (ovalbumin), member 1;
SERPINB6
serpin peptidase inhibitor, clade B (ovalbumin), member 6
SERPINB6; serpin peptidase inhibitor, clade B (ovalbumin), member 6; deafness, autosomal recessive 91 , DFNB91, PI6, serine (or cysteine) proteinase inhibitor, clade B (ovalbumin), member 6; serpin B6; CAP; cytoplasmic antiproteinase; PTI; MGC111370; MSTP057; Peptidase inhibitor 6; PI 6; PI-6; PI6; Placental thrombin inhibitor; Protease inhibitor 6; Protease inhibitor 6 (placental thrombin inhibitor); Serpin peptidase inhibitor clade B (ovalbumin) member 6; SPB6_HUMAN; serine (or cysteine) proteinase inhibitor, clade B (ovalbumin), member 6; SPI3; DFNB91;
SERPINB8
serpin peptidase inhibitor, clade B (ovalbumin), member 8
SERPINB8; serpin peptidase inhibitor, clade B (ovalbumin), member 8; PI8, serine (or cysteine) proteinase inhibitor, clade B (ovalbumin), member 8; serpin B8; CAP2; cytoplasmic antiproteinase 2; CAP 2; CAP-2; OTTHUMP00000067000; OTTHUMP00000067001; Peptidase inhibitor 8; PI-8; PI8; Protease inhibitor 8 (ovalbumin type); Serine (or cysteine) proteinase inhibitor clade B (ovalbumin) member 8; Serpin peptidase inhibitor clade B (ovalbumin) member 8; SPB8_HUMAN; serine (or cysteine) proteinase inhibitor, clade B (ovalbumin), member 8;
SERPINB9
serpin peptidase inhibitor, clade B (ovalbumin), member 9
SERPINB9; serpin peptidase inhibitor, clade B (ovalbumin), member 9; PI9, serine (or cysteine) proteinase inhibitor, clade B (ovalbumin), member 9; serpin B9; CAP3; peptidase inhibitor 9; cytoplasmic antiproteinase 3; protease inhibitor 9 (ovalbumin type;
SERPINB14
serpin peptidase inhibitor, clade B (ovalbumin), member 14
SERPINB14; Ovalbumin; egg albumin; plakalbumin; allergen Gal d II;
SERPINB13
serpin peptidase inhibitor, clade B (ovalbumin), member 13
SERPINB13; serpin peptidase inhibitor, clade B (ovalbumin), member 13; PI13, serine (or cysteine) proteinase inhibitor, clade B (ovalbumin), member 13; serpin B13; headpin; HUR7; hurpin; HaCaT UV repressible serpin; HaCaT UV-repressible serpin; HSHUR7SEQ; MGC126870; Peptidase inhibitor 13; PI-13; PI13; Protease inhibitor 13; Proteinase inhibitor 13; Serine (or cysteine) proteinase inhibitor clade B (ovalbumin) member 13; Serpin peptidase inhibitor clade B (ovalbumin) member 13; SPB13_HUMAN; UV B repressed sequence HUR 7; UV-B repressed sequence, HUR 7; protease inhibitor 13 (hurpin, headpin); serine (or cysteine) proteinase inhibitor, clade B (ovalbumin), member 13;
SERPINB11
serpin peptidase inhibitor, clade B (ovalbumin), member 11 (gene/pseudogene)
SERPINB11; serpin peptidase inhibitor, clade B (ovalbumin), member 11 (gene/pseudogene); serine (or cysteine) proteinase inhibitor, clade B (ovalbumin), member 11 , serpin peptidase inhibitor, clade B (ovalbumin), member 11; serpin B11; EPIPIN; Serine (or cysteine) proteinase inhibitor clade B (ovalbumin) member 11; Serpin peptidase inhibitor clade B (ovalbumin) member 11; SERPINB11d; SERPINB11e; SERPINB11f; serine (or cysteine) proteinase inhibitor, clade B (ovalbumin), member 11; SERPIN11;
SERPINB7
serpin peptidase inhibitor, clade B (ovalbumin), member 7
SERPINB7; serpin peptidase inhibitor, clade B (ovalbumin), member 7; serine (or cysteine) proteinase inhibitor, clade B (ovalbumin), member 7; serpin B7; MEGSIN; Mesangium predominant gene megsin; MGC120014; MGC120015; Serpin peptidase inhibitor clade B (ovalbumin) member 7; TP55; mesangium predominant gene, megsin;
SPO11
SPO11 meiotic protein covalently bound to DSB homolog (S. cerevisiae)
SPO11; SPO11 meiotic protein covalently bound to DSB homolog (S. cerevisiae); SPO11 meiotic protein covalently bound to DSB like (S. cerevisiae) , SPO11, meiotic protein covalently bound to DSB (S. cerevisiae) like; meiotic recombination protein SPO11; cancer/testis antigen 35; CT35; Meiotic recombination protein SPO 11; MGC39953; SPO 11; SPO11 meiotic protein covalently bound to DSB homolog; SPO11 meiotic protein covalently bound to DSB like;
Endotoxin Removal Service
Creative BioMart provides service to remove endotoxins (lipopolysaccharides /LPS) from aqueous solutions of a wide range of samples such as proteins, antibodies, vaccines, nucleic acids, buffers and cell extracts with excellent sample recovery rate. Each Endotoxin Removal project requires a protoc...
Glybera became the first one that gets gene therapy approval
The first gene therapy for rare disease gets approval by European Commission This is an important news about gene therapy. After years of development and repeated rejections, uniQure finally got permission to market its gene therapyGlybera. Glybera was designed for certain patients with lipoprote...
The New Diabetes Drug of Novo Nordisk A/S (NVO) Get Approval by FDA
Novo Nordisk is a global healthcare company with 89 years of innovation and leadership in diabetes care. On Nov. 8, 2012, the Endocrinologic and Metabolic Drugs Advisory Committee of the United States Food and Drug Administration (FDA) completed the New Drug Application (NDA) for insulin degludec...
The Last FDA Approvals in 2012 for World Pharma Regulatory Blockbusters (From Dec. 21 to Dec. 31)
On Dec. 31, 2012, the last day of the year, the FDA came through with a rapid-fire approval of Johnson Johnson's bedaquiline, the first new treatment for drug-resistant tuberculosis in four decades. The approval was based on mid-stage data after JJ ($JNJ) made its case that the urgent nee...
The FDA Approval of Flublok
On Jan. 16, 2013, the U.S. Food and Drug Administration (FDA) announced the approval of Flublok for the prevention of seasonal influenza in people aged from 18 to 49. Flublok is the first trivalent influenza vaccine that uses baculovirus expression system and novel recombinant DNA technology. The t...
The Worldwide Biotech’s Approval or Restricting by FDA (From Feb. 15 to Feb. 22)
On Feb 22, 2013, Roche's ($RHHBY) Genentechpicked up FDA approval for its late-stage breast cancer therapy Kadcyla, formerly T-DM1, which uses antibodies to deliver cancer drugs directly to the offending cells. The treatment combinesImmunoGen's ($IMGN)taxane chemotherapy drug, DM1, with an ant...
